Viz.ai announced the FDA clearance of its new RV/LV ratio algorithm, adding an important risk stratification feature to its pulmonary embolism AI module, while representing an interesting example of how triage AI solutions might evolve.
Triage + Stratification + Coordination – Viz PE becomes far more comprehensive with its new RV/LV integration, helping radiologists detect/prioritize PE cases and assess right heart strain (a major cause of PE mortality), while equipping PE response teams with more actionable information.
- This addition might also improve clinicians’ experience with Viz PE, noting the risk of developing AI “alert fatigue” when all severity levels are treated the same.
Viz.ai is So On-Trend – Signify Research recently forecast that AI leaders will increasingly expand into new clinical segments, enhance their current solutions, and leverage platform / marketplace strategies, as AI evolves from point solutions to comprehensive workflows. Those trends are certainly evident within Viz.ai’s recent PE strategy…
- Viz PE’s late 2021 launch was a key step in Viz.ai’s expansion beyond neuro/stroke
- Adding RV/LV risk stratification certainly enhances Viz PE’s detection capabilities
- Viz PE was developed by Avicenna.AI, arguably making Viz.ai a platform vendor
- Viz PE’s workflow now combines detection, assessment, and care coordination
The same could be said for Aidoc, which previously added Imbio’s RV/LV algorithm to its PE AI solution (and also supports incidental PE), although few other triage AI workflows are this advanced for PE or other clinical areas.
The Takeaway
Viz.ai’s PE and RV/LV integration is a great example of how detection-focused AI tools can evolve through risk/severity stratification and workflow integration — and it might prove to be a key step in Viz.ai’s expansion beyond stroke AI.
